Regeneron Pharmaceuticals Inc (REGN)

569.17 +6.46  +1.15% NASDAQ Oct 21, 16:00 568.33 -0.84  -0.15% After-Hours: 19:17 USD
View Full Chart
Price Chart
View All REGN News

News

View All Events

Events

Date Type Description
11/04/2021 Earnings Results Q3 2021 Earnings Results
11/04/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
06/11/2021 10:30 EST AGM 2021 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
02/05/2021 Earnings Results Q4 2020 Earnings Results
02/05/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 08:30 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.
  • URL: http://www.regeneron.com
  • Investor Relations URL: https://newsroom.regeneron.com/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Nov. 04, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
IBB iShares Biotechnology ETF 4.52%
FBT First Trust NYSE Arca Biotech ETF 3.41%
LGRCX Loomis Sayles Growth C 2.93%
VGHCX Vanguard Health Care Inv 2.77%
ARKG ARK Genomic Revolution ETF 2.23%
PEQNX Putnam Large Cap Value B 2.03%
AULNX American Century Ultra® G 1.76%
USMV iShares MSCI USA Min Vol Factor ETF 1.27%
FOCKX Fidelity® OTC K 1.16%
VHT Vanguard Health Care ETF 1.13%
ACWV iShares MSCI Global Min Vol Factor ETF 1.13%
FCNKX Fidelity® Contrafund® K 0.91%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.